ArticleScientific reports2026
Artificial intelligence-assisted optimization of Lentinula edodes extracts for enhanced bioactive profile and therapeutic potential.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Edible and Medicinal Mushrooms as Sources of Bioactive Molecules in Pregnancy: Potential Impact on Preeclampsia and Gestational Diabetes Outcomes.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, extraction parameters to increase the biological activities of Lentinula edodes extracts were optimized using both Response Surface Methodology (RSM) and Artificial Neural Network-Genetic Algorithm (ANN-GA) hybrid models. Antioxidant, anticholinesterase, antiproliferative activities, and phenolic contents of the extracts obtained under optimum conditions were determined. According to the findings of the study, it was determined that the extracts obtained with ANN-GA optimization had higher TAS (6.612 mmol/L), FRAP (176.25 mg TE/g), and DPPH (133.00 mg TE/g) values compared to RSM. In addition, TOS (4.167 µmol/L) and OSI (0.063) levels were lower. In anticholinesterase assays, ANN-GA extracts were found to be more effective than RSM in inhibiting AChE (72.47 µg/mL) and BChE (132.13 µg/mL). Furthermore, in antiproliferative assays on A549, MCF-7, and DU-145 cancer cell lines, ANN-GA-optimized extracts were observed to have stronger cytotoxic effects. LC-MS/MS analyses revealed that ANN-GA optimization enriched biologically important phenolic compounds such as gallic acid, protocatechuic acid, and caffeic acid at higher levels. Consequently, AI-assisted optimization offers a powerful strategy for enhancing the biological value of mushroom extracts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.